Mario Polywka
Vorstandsvorsitzender bei EVOTEC SE
Vermögen: 372 498 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Zachary A. Zimmerman | M | - |
Forge Therapeutics, Inc.
 Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA.
Blacksmith Medicines, Inc.
 Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | - |
| David Hallett | M | 54 | 4 Jahre | |
| Iris Löw-Friedrich | M | 63 | 10 Jahre | |
| Elizabeth Crain | F | 59 | 3 Jahre | |
| Stephen Worland | M | 66 |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA.
Blacksmith Medicines, Inc.
Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | 7 Jahre |
| Laetitia Rouxel | F | 51 | 1 Jahre | |
| Andrew Tomaras | M | - |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | 3 Jahre |
| Dan Ireland | M | - | - | |
| Brian Dorsey | M | 55 |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA.
Blacksmith Medicines, Inc.
Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | 7 Jahre |
| Gabriele Hansen | F | - | - | |
| David Puerta | M | - |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | - |
| Ben Taylor | M | 46 | 4 Jahre | |
| Craig Johnstone | M | 54 | 12 Jahre | |
| Volker Braun | M | - | - | |
| Nick Dixon Clegg | M | - |
Orbit Discovery Ltd.
 Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Franziska Michor | M | 41 | 1 Jahre | |
| Eileen Jennings-Brown | F | - | 2 Jahre | |
| Roland Sackers | M | 56 | 5 Jahre | |
| Hinnerk Rohwedder | M | - | 3 Jahre | |
| Matthias Evers | M | 51 | 2 Jahre | |
| Michael Krams | M | 63 | 2 Jahre | |
| Phil Ferneau | M | 62 |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | 6 Jahre |
| Constanze Ulmer-Eilfort | M | 62 | 3 Jahre | |
| Cord Dohrmann | M | 60 | 14 Jahre | |
| Chris Thomas | M | - | 5 Jahre | |
| Terence H. Rabbitts | M | - |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | - |
| Richard Henry Cheetham Bickerton | M | 80 | 3 Jahre | |
| Satish Azad Nadimpally Varma | M | 55 |
Evotec (India) Pvt Ltd.
 Evotec (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Research Support International Pvt Ltd. provides drug discovery & development services. Its facilities include analytical, synthetic, kilo, hydrogenation, humidity control and hazardous reactions labs. The company is headquartered in Thane, India. | - |
| Robert Ghenchev | M | 41 | 4 Jahre | |
| Thomas Mccarthy | M | - |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | - |
| Camilla Languille | F | 41 | 2 Jahre | |
| Caroline Rowland | F | - | 2 Jahre | |
| Sara Blum Sherman | F | - | 3 Jahre | |
| John Overington | M | - | 3 Jahre | |
| Graham Ogg | M | - |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | 9 Jahre |
| Elaine Sullivan | M | 63 | 9 Jahre | |
| John Schmid | M | 61 |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | 7 Jahre |
| Neil Butt | M | - |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | 3 Jahre |
| Seth Cohen | M | - |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | - |
| Parker Moss | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Werner Lanthaler | M | 56 | 15 Jahre | |
| Andrew Hopkins | M | 52 | 12 Jahre | |
| Jason Evans | M | - |
University of Oxford
| 9 Jahre |
| Michael Barrow | M | - |
University of Oxford
| 3 Jahre |
| David J. W. Bailey | M | - |
University of Oxford
| 4 Jahre |
| Flemming Ørnskov | M | 66 | - | |
| Klaus Maleck | M | 51 | - | |
| Paul Herrling | M | 78 | 3 Jahre | |
| Kevin L. Thurm | M | 62 |
University of Oxford
| 1 Jahre |
| Daniel Kapi | M | - |
University of Oxford
| 5 Jahre |
| Elizabeth Phelps | F | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Wolfgang Plischke | M | 72 | 7 Jahre | |
| Matt Greenwood | M | - |
University of Oxford
| 3 Jahre |
| Tai Lok Lui | M | 66 |
University of Oxford
| 5 Jahre |
| C. Nicholson | M | 68 | 4 Jahre | |
| Doron Junger | M | - |
University of Oxford
| 6 Jahre |
| Robin N. Lowe | M | 59 |
University of Oxford
| 4 Jahre |
| Craig Fox | M | - | 7 Jahre | |
| Man Wai Chiu | M | 55 |
University of Oxford
| 5 Jahre |
| Rupert Charles de Borchgrave d'Altena | M | - |
University of Oxford
| 7 Jahre |
| Charmion Gillmore | F | - | - | |
| Landon Clay | M | 98 |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Harry Finch | M | - | 8 Jahre | |
| Simon H. Thomas | M | 64 |
University of Oxford
| 5 Jahre |
| Walter Wenninger | M | 86 | 6 Jahre | |
| Bernd Hirsch | M | 53 | - | |
| Claus Tycho Bræstrup | M | 79 | - | |
| Stephen Swaffield | M | 61 |
University of Oxford
| 6 Jahre |
| Edwin Moses | M | 69 |
Oxford Asymmetry International Plc
| 8 Jahre |
| Dirk H. Ehlers | M | 63 | 6 Jahre | |
| Timm H. Jessen | M | 62 | 7 Jahre | |
| Jörn Aldag | M | 65 | 11 Jahre | |
| Emma Cookson | F | - |
University of Oxford
| 3 Jahre |
| Michael Stein | M | 60 |
University of Oxford
| 4 Jahre |
| Simon Munton Bullivant | M | - |
University of Oxford
| 4 Jahre |
| Greg Eckersley | M | 59 |
University of Oxford
| 4 Jahre |
| Edward Sims | M | 60 |
University of Oxford
| 4 Jahre |
| Zachary Karabell | M | - |
University of Oxford
| 2 Jahre |
| Ian Jauncey | M | - |
University of Oxford
| 3 Jahre |
| Duncan R. Reid-Thomas | M | - |
University of Oxford
| 4 Jahre |
| Andrew Edward Anson | M | 59 |
University of Oxford
| 3 Jahre |
| Christopher Hodges | M | 56 |
University of Oxford
| 3 Jahre |
| Yvonne Muthien | M | 67 |
University of Oxford
| 4 Jahre |
| James C. Clarke | M | - |
University of Oxford
| 4 Jahre |
| Alison Wood | F | 61 |
University of Oxford
| 4 Jahre |
| Jason Pontin | M | - |
University of Oxford
| 3 Jahre |
| Valerie Monchi | F | - |
University of Oxford
| 4 Jahre |
| Timothy R. J. Stubbs | M | 56 |
University of Oxford
| 4 Jahre |
| Koosum P. Kalyan | F | 68 |
University of Oxford
| 4 Jahre |
| David Charles Hawkins | M | 58 |
University of Oxford
| 1 Jahre |
| Matthew James Whittell | M | - |
University of Oxford
| 4 Jahre |
| Christoph Matthias Widmer | M | 57 |
University of Oxford
| 4 Jahre |
| Jeremy John Austin | M | 60 |
University of Oxford
| 1 Jahre |
| Su-Mei Thompson | F | 57 |
University of Oxford
| 3 Jahre |
| Neill Penney | M | - |
University of Oxford
| 4 Jahre |
| Doug Bewsher | M | 55 |
University of Oxford
| 1 Jahre |
| Fariba Fischel Ghodsian | M | - |
University of Oxford
| 3 Jahre |
| Jai Swaroop Pathak | M | 65 |
University of Oxford
| 1 Jahre |
| Eleni D. Dendrinou-Louri | M | 70 |
University of Oxford
| 4 Jahre |
| Kate Philips | F | - |
University of Oxford
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 68 | 68,00% |
| Deutschland | 24 | 24,00% |
| Vereinigte Staaten | 7 | 7,00% |
| Indien | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mario Polywka
- Persönliches Netzwerk
